Search
for
Sort by
Research 301–330 of 1000+
- Estudio clínico-patológico sobre el cáncer de próstata incidental en pacientes intervenidos bajo el supuesto diagnóstico de HBP sintomática
- Tratamientos fitoterapeúticos para la hipertrofia benigna de próstata: serenoa repens
- Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate Cancer
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Androgen Receptor Mutations and Polymorphisms in African American Prostate Cancer
- Multiple readout assay for hormonal (androgenic and antiandrogenic) and cytotoxic activity of plant and fungal extracts based on differential prostate cancer cell line behavior
- In vitro [7-3H]-testosterone metabolism by the rat ventral prostate—Effect of some exogenous compounds
- Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment
- Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study
- Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study
- Modulation of the canonical Wnt activity by androgen signaling in prostate epithelial basal stem cells
- Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2
- Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
- Re: Association of Treatment with 5α-Reductase Inhibitors with Time to Diagnosis and Mortality in Prostate Cancer
- Alopecia androgénica como factor predictor de hiperplasia benigna de próstata
- Topical Application of Thermobalancing Therapy Enabled by Therapeutic Device Treats Enlarged Prostate and Improves Men's Quality of Life; New Opportunity in BPH Treatment
- 342 COMPARISON OF THE INCIDENCE OF SECONDARY CANCERS AFTER IMRT, BRACHYTHERAPY AND SURGERY FOR THE TREATMENT OF PROSTATE CANCER
- UP-02.009 Clinical Significance of Intravesical Prostatic Protrusion/Prostate Volume
- S88 Does cone beam computed tomography decrease CTV's margins in prostate cancer radiation treatment?
- S87 Image guided radiotherapy (IGRT) in stage III prostate cancer: analysis of acute toxicity
- Control of testosterone 5alpha-reductase activity in the human hyperplastic prostate
- The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer
- Effects of Short-Term Finasteride on Apoptotic Factors and Androgen Receptors in Prostate Cancer Cells
- 4‐MAPC, a 5α‐Reductase Inhibitor, Reduces Rat Ventral Prostate Weight, DNA, and Prostatein Concentrations
- An observational study of the association between androgenetic alopecia and size of the prostate
- A new look at an old option in the treatment of early-stage prostate cancer: hormone therapy as an alternative to watchful waiting
- Expression and Cellular Localization of Keratinocyte Growth Factor and Its Receptor in Human Hyperplastic Prostate Tissue<sup>1</sup>
- Combined oral contraceptives promote androgen receptor and oestrogen receptor alpha upregulation in the female prostate (Skene’s paraurethral glands) of adult gerbils (Meriones unguiculatus)
- Low‐dose in utero exposure to finasteride promotes developmental changes in both male and female gerbil prostates
- A comparison of the cytotoxic effects of fatty acids on in vitro breast and prostate cell lines